Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Adenocarcinoma and FLT1[original query] |
---|
VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials. The Lancet. Oncology 2012 Jul 13 (7): 724-33. Lambrechts Diether, Claes Bart, Delmar Paul, Reumers Joke, Mazzone Massimiliano, Yesilyurt Betül T, Devlieger Roland, Verslype Chris, Tejpar Sabine, Wildiers Hans, de Haas Sanne, Carmeliet Peter, Scherer Stefan J, Van Cutsem Er |
Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome. Carcinogenesis 2015 Sep 36 (9): 956-62. Eng Lawson, Azad Abul Kalam, Qiu Xin, Kong Qin Quinn, Cheng Dangxiao, Ying Nanjiao, Tse Alvina, Kuang Qin, Dodbiba Lorin, Renouf Daniel J, Marsh Sharon, Savas Sevtap, Mackay Helen J, Knox Jennifer J, Darling Gail E, Wong Rebecca K S, Xu Wei, Liu Geoffrey, Faluyi Olusola |
Immune-related somatic mutation genes are enriched in PDACs with diabetes. Translational oncology 2019 Jun 12 (9): 1147-1154. Wang Kaixuan, Zhou Wei, Meng Peng, Wang Peng, Zhou Chunhua, Yao Yao, Wu Shouxin, Wang Yu, Zhao Jiangman, Zou Duowu, Jin Ga |
Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer. Oncology research 2023 9 31 (6): 855-866. Sung Hee Lim, Hee Jin Cho, Kyoung-Mee Kim, Ho Yeong Lim, Won Ki Kang, Jeeyun Lee, Young Suk Park, Hee Cheol Kim, Seung Tae K |
Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma. Journal of translational medicine 2024 4 22 (1): 330. Long Zhang, Yajun Xiong, Jie Zhang, Yuying Feng, Aiguo |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: